The interplay between immunosenescence and microbiota in the efficacy of vaccines

29Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Vaccinations are among the most effective medical procedures and have had an incredible impact on almost everyone’s life. One of the populations that can benefit the most from them are elderly people. Unfortunately, in this group, vaccines are less effective than in other groups, due to immunosenescence. The immune system ages like the whole body and becomes less effective in responding to infections and vaccinations. At the same time, immunosenescence also favors an inflammatory microenvironment, which is linked to many conditions typical of the geriatrics population. The microbiota is one of the key actors in modulating the immune response and, in this review, we discuss the current evidence on the role of microbiota in regulating the immune response to vaccines, particularly in elderly people.

Cite

CITATION STYLE

APA

Cianci, R., Franza, L., Massaro, M. G., Borriello, R., De Vito, F., & Gambassi, G. (2020, December 1). The interplay between immunosenescence and microbiota in the efficacy of vaccines. Vaccines. MDPI AG. https://doi.org/10.3390/vaccines8040636

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free